id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0018-0437,FDA,FDA-1978-N-0018,Letter from FDA/CDER to The Procter & Gamble Company,Other,Letter(s),1999-11-08T05:00:00Z,1999,11,,,2019-07-26T12:27:36Z,,0,0,090000648055a6a5
FDA-1978-N-0018-0436,FDA,FDA-1978-N-0018,"Letter from FDA/CDER to The Cosmetic, Toiletry & Fragrance Association",Other,Letter(s),1999-08-03T04:00:00Z,1999,8,,,2019-07-25T18:01:31Z,,0,0,090000648055a696
FDA-1978-N-0018-0434,FDA,FDA-1978-N-0018,Sunscreen Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment,Notice,Notice of Final Rule,1999-05-28T04:00:00Z,1999,5,1999-05-28T04:00:00Z,2000-05-23T03:59:59Z,2019-07-26T18:25:19Z,01–15632,0,0,090000648055a68d
FDA-1978-N-0018-0435,FDA,FDA-1978-N-0018,Sunscreen Drug Products For Over-The-Counter Human Use; Final Monograph,Notice,Notice of Final Rule,1999-05-28T04:00:00Z,1999,5,1999-05-28T04:00:00Z,2000-05-23T03:59:59Z,2019-08-01T17:11:15Z,99-12853,0,0,090000648055a68f
FDA-1978-N-0018-0433,FDA,FDA-1978-N-0018,Revocation of Advisory Opinion Entitled “FD&C Act Trade Correspondence 61”,Notice,General Notice,1999-05-26T04:00:00Z,1999,5,,,2019-08-01T17:13:45Z,99-12854,0,0,090000648055a688
FDA-1978-N-0018-0808,FDA,FDA-1978-N-0018,Supplement from Merck KGaA,Other,Supplement,1999-05-11T04:00:00Z,1999,5,,,2019-08-09T14:28:06Z,,0,0,0900006481a795c8
FDA-1978-N-0018-0432,FDA,FDA-1978-N-0018,"Acknowledgment Letter from FDA DDM to The Cosmetic, Toiletry & Fragrance Association",Other,Acknowledgement Letter/Receipt,1999-04-15T04:00:00Z,1999,4,,,2019-07-26T12:31:38Z,,0,0,090000648055a64e